Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FN2C6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,931
Award facts
- Contract value 100% obligated
- $55,931.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, with a ceiling value of $55,931.40 for RINVOQ ER 15 MG tablets (30-count units). This competitive, non-set-aside contract employs firm fixed-price pricing and is scheduled for completion by February 5, 2026. The award supports the company's performance under its parent entity Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2031. This prime vehicle enables comprehensive pharmaceutical supply chain support for military healthcare systems globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's performance under this delivery order supports DLA's mission to supply essential pharmaceutical products to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure and compressed delivery timeline reflect typical operational practices for replenishment orders under the DLA Troop Support Medical IDC, demonstrating the contractor's capability to efficiently fulfill government pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DR26FN2C6?
SPE2DR26FN2C6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FN2C6 worth?
The government has obligated $55,931 on SPE2DR26FN2C6.
Is contract SPE2DR26FN2C6 an order under another contract?
Yes. SPE2DR26FN2C6 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN2C6 competed?
The extent of competition for SPE2DR26FN2C6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award